3

MAIN DOCUMENT DESCRIPTION

Company: Protalix BioTherapeutics, Inc.
Filed: September 8, 2008
Period of Report: February 7, 2008
Accession Number: 0001209191-08-050992

View Document ↗ View on SEC.gov ↗